Covered recipient · General Payments record
ANDREW SEFAIN
Allopathic & Osteopathic Physicians Internal Medicine Adolescent Medicine
General Payments · PY2023–2024
$350.07
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $323.37 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $125.00 | 1 |
| ACADIA Pharmaceuticals Inc | $91.33 | 3 |
| EMD Serono, Inc. | $36.32 | 2 |
| EISAI INC. | $23.79 | 1 |
| ABBVIE INC. | $17.73 | 1 |
| ARGENX US, INC. | $15.83 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.73 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106051606 | CMS |
| ACADIA Pharmaceuticals Inc | $20.80 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147992361 | CMS |
| ACADIA Pharmaceuticals Inc | $32.14 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147992364 | CMS |
| ACADIA Pharmaceuticals Inc | $38.39 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147992368 | CMS |
| ARGENX US, INC. | $15.83 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142109025 | CMS |
| Eisai Inc. | $23.79 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110729587 | CMS |
| EMD Serono, Inc. | $21.45 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120256729 | CMS |
| EMD Serono, Inc. | $14.87 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120268474 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.37 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151602385 | CMS |
| UCB, Inc. | $125.00 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143076920 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.